Abstract:Changes in mitochondrial bioenergetics in aging T-cells play a key role in the decrease in T-cell function and tumor resistance with aging. The bioactive sphingolipid ceramide, induced by aging stress, is a major player in these changes, as its accumulation at the mitochondrial membranes of both mouse and human aging T-cells induces ceramide-dependent mitophagy, which decreases T-cell viability, cytokine secretion, and anti-tumor activity. Using knock-out mouse models and pharmacological inhibition, we show that C14-ceramide accumulation in the mitochondria and mitophagy in the T-cells of aging mice are dependent on Ceramide Synthase 6 (CerS6), an enzyme responsible for C14/C16-ceramide synthesis. Interestingly, sphingosine kinase 2 (SphK2), another enzyme involved in ceramide metabolism inhibits HDAC1/2 function in aging T-cells, epigenetically inducing CerS6 expression and the resultant ceramide-dependent mitophagy, which ultimately decreases T-cell anti-tumor function. Both CerS6-/- and SphK2-/- aging T-cells were protected from the reduction in T-cell function, and their anti-tumor function was maintained in adoptive-cell transfer experiments to mice with melanoma. Besides lipid signaling, other metabolic changes associated with this aging-induced process have not been explored, and the utility of correcting these metabolic changes to restore T-cell function has not been evaluated. We studied the total hydrophilic metabolome of aging T-cells undergoing ceramide-dependent mitophagy to assess the metabolic changes occurring in these cells. Our findings show a general depletion of tricarboxylic acid cycle (TCA) metabolites in aging T-cells, with pools of fumarate, malate, and argininosuccinate significantly decreasing in both mouse and human aging T-cells. Interestingly, these changes were mirrored by similar changes in human cancer cells undergoing ceramide-dependent mitophagy, suggesting that these changes might constitute a general metabolic signature for this specific mitophagy process with deleterious effects on anti-tumor functions of aging T-cells. Both in vitro and in vivo supplementation of fumarate to mouse T-cells seemed to correct some of the functional defects observed in aging, with a protection of T-cell viability, cytokine production, and tumor killing capacity in co-cultures with tumor cells. The fumarate supplementation also led to a decrease in ceramide-dependent mitophagy in the aging T-cells, indicating an interplay between ceramide-dependent mitophagy and fumarate metabolism. Overall, these studies help explain the mechanisms behind aging-related dysregulation of T-cell anti-tumor activity, which can be restored by inhibiting ceramide-dependent mitophagy by pharmacological and genetic tools or by reprogramming fumarate metabolism in aging T cells. Citation Format: Mohamed Faisal Kassir, Han Gyul Lee, Natalia Oleinik, Paramita Chakraborty, John J. Lemasters, Zdzislaw Szulc, Xue-Zhong Yu, Shikhar Mehrotra, Besim Ogretmen. Ceramide-dependent mitophagy leads to metabolic reprogramming in aging T-cells associated with reduced anti-tumor T-cell functions [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited s); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl) nr 2867.

Inhibiting de novo ceramide synthesis restores mitochondrial and protein homeostasis in muscle aging

Inhibition of CERS1 in skeletal muscle exacerbates age-related muscle dysfunction

Targeting Mitochondrial Quality Control in Muscle Aging: Natural Dietary Products As Potential Interventions

Inhibition of in skeletal muscle exacerbates age-related muscle dysfunction

NAD+ boosting reduces age-associated amyloidosis and restores mitochondrial homeostasis in muscle

Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence

Aging-dependent Mitochondrial Dysfunction Mediated by Ceramide Signaling Inhibits Antitumor T Cell Response

Methionine adenosyltransferase2A inhibition restores metabolism to improve regenerative capacity and strength of aged skeletal muscle

Nicotinamide and pyridoxine stimulate muscle stem cell expansion and enhance regenerative capacity during aging

Myricanol prevents aging-related sarcopenia by rescuing mitochondrial dysfunction via targeting peroxiredoxin 5

Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and health span in C. elegans

3D Mitochondrial Structure in Aging Human Skeletal Muscle: Insights into MFN-2 Mediated Changes

Abstract 2867: Ceramide-dependent mitophagy leads to metabolic reprogramming in aging T-cells associated with reduced anti-tumor T-cell functions

Restoration of CPEB4 prevents muscle stem cell senescence during aging

Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging

Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate

Effects of Aging and Caloric Restriction on Fiber Type Composition, Mitochondrial Morphology and Dynamics in Rat Oxidative and Glycolytic Muscles

Reduced energy metabolism contributing to aging of skeletal muscle by serum metabolomics and gut microbiota analysis

Mitochondrial Quantity and Quality in Age-Related Sarcopenia

Skeletal muscle mitochondrial interactome remodeling is linked to functional decline in aged female mice

Muscle-specific PGC-1α modulates mitochondrial oxidative stress in aged sarcopenia through regulating Nrf2